Zura Bio Limited Announces Share Redemptions and Lock-up Agreement

Author's Avatar
Mar 27, 2023

As previously announced on March 21, 2023, Zura Bio Limited (“Zura”), a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders, announced the closing of its business combination with JATT Acquisition Corp (“JATT”), a special purpose acquisition company.